Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery

This study has been completed.
Information provided by (Responsible Party):
Action Pharma A/S Identifier:
First received: December 5, 2010
Last updated: March 14, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2011
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)